Diabetes treatment is constantly evolving, with new therapeutic options emerging to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the actions https://nanniefsec707017.blogzag.com/82390476/promising-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment